No Data
No Data
No Data
No Data
No Data
Zhong Yuan Bio-Technology Downsizes Proposed Uplisting Offering
Seeking AlphaAug 24, 2023 02:48
Zhong Yuan Bio-Technology, Now on OTC and Seeking Nasdaq Listing, Expects to Offer 1M Shrs at Price Between $5 and $7 Each
Zhong Yuan Bio-Technology, Now on OTC and Seeking Nasdaq Listing, Expects to Offer 1M Shrs at Price Between $5 and $7 Each
Dow JonesAug 23, 2023 06:09
Zhong Yuan Bio-Technology Updates Terms for $7.5M Offering, Uplisting
Seeking AlphaMar 4, 2023 06:02
Chinese dietary supplement manufacturer Zhongyuan Biotech plans to transfer to Nasdaq listing to raise $10 million
Zhitong Finance App learned that on Wednesday, Chinese cognitive health neuric acid dietary supplement manufacturer Zhongyuan Biotech announced its IPO terms. The company is currently listed on OTC under the stock code “ZHYBF”. According to the prospectus, the Hong Kong-based company plans to issue 2 million shares at $4-6 (25% will be a secondary offering) to raise $10 million. Based on the midpoint of the proposed range, the market value of Zhongyuan Biotech will reach 96 million US dollars. According to information, through the operation of its subsidiary Baofeng Biotech, the company is engaged in neuric acid research and development of herbal medicines and chemical drugs based on neuric acid,
Zhitong FinanceMar 2, 2023 09:35
No Data
No Data